NPO(NPO)
NPO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.28B | $1.36B |
| Low | $1.27B | $1.36B |
| High | $1.29B | $1.37B |
| EBITDA Avg | $260M | $277M |
| Low | $258M | $275M |
| High | $261M | $278M |
| EBIT Avg | $126M | $134M |
| Low | $125M | $133M |
| High | $126M | $134M |
| Net Income Avg | $193M | $218M |
| Low | $192M | $210M |
| High | $194M | $225M |
| EPS Avg | $9.21 | $10.36 |
| Low | $9.15 | $10.01 |
| High | $9.25 | $10.71 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $326M | $332M | $330M | $345M | $344M | $346M |
| Low | $325M | $330M | $328M | $342M | $342M | $344M |
| High | $326M | $335M | $333M | $348M | $347M | $350M |
| EBITDA Avg | $66M | $67M | $67M | $70M | $70M | $70M |
| Low | $66M | $67M | $66M | $69M | $69M | $70M |
| High | $66M | $68M | $68M | $71M | $70M | $71M |
| EBIT Avg | $32M | $33M | $32M | $34M | $34M | $34M |
| Low | $32M | $32M | $32M | $34M | $33M | $34M |
| High | $32M | $33M | $33M | $34M | $34M | $34M |
| Net Income Avg | $49M | $51M | $54M | $57M | $57M | $57M |
| Low | $48M | $51M | $53M | $57M | $56M | $56M |
| High | $49M | $52M | $54M | $58M | $57M | $58M |
| EPS Avg | $2.31 | $2.43 | $2.55 | $2.72 | $2.69 | $2.70 |
| Low | $2.29 | $2.41 | $2.53 | $2.70 | $2.67 | $2.68 |
| High | $2.33 | $2.46 | $2.58 | $2.75 | $2.72 | $2.73 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |